Document is current
Any future updates will be listed below
-
Authors
Itoh, Noriko
Itoh, Yuichiro
Patil, Rajita
Till, Christi
Smith, Marissa
Schwartz, Jaclyn
Davis, Brittany
Oberman, Erica
Romeroso, Brianne D.
Voskuhl, Rhonda R. https://orcid.org/0000-0003-2620-4346
-
Funding
Funding for this research was provided by:
National Institutes of Health (R35NS132150, R01NS096748 and R01NS109670)
Conrad N. Hilton Foundation (17734 and 18394)
Race to Erase MS
- License Information
-
More Information
Article History
Received: 7 October 2025
Accepted: 3 August 2026
First Online: 1 September 2026
Declarations
Competing interest: R.R.V. is an inventor on UCLA’s patents pertaining to hormone treatment for cognition and is an Advisor for Cleopatrarx, LLC, the company that licensed UCLA patents. C.T. assists with education and outreach to menopausal women through The Cleopatrarx Foundation, a nonprofit organization. Other authors have nothing to disclose.
